HUP0201877A2 - Hal zselatint tartalmazó, gyorsan diszpergálódó dózis formák - Google Patents

Hal zselatint tartalmazó, gyorsan diszpergálódó dózis formák

Info

Publication number
HUP0201877A2
HUP0201877A2 HU0201877A HUP0201877A HUP0201877A2 HU P0201877 A2 HUP0201877 A2 HU P0201877A2 HU 0201877 A HU0201877 A HU 0201877A HU P0201877 A HUP0201877 A HU P0201877A HU P0201877 A2 HUP0201877 A2 HU P0201877A2
Authority
HU
Hungary
Prior art keywords
fast
dosage forms
fish gelatin
active ingredient
dispersing dosage
Prior art date
Application number
HU0201877A
Other languages
English (en)
Inventor
Richard Green
Michael Hall
Patrick Kearney
Owen Murray
Original Assignee
R.P. Scherer Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R.P. Scherer Corporation filed Critical R.P. Scherer Corporation
Publication of HUP0201877A2 publication Critical patent/HUP0201877A2/hu
Publication of HUP0201877A3 publication Critical patent/HUP0201877A3/hu
Publication of HU229892B1 publication Critical patent/HU229892B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Abstract

A találmány tárgya gyógyszerkészítmény gyorsan diszpergálódó dózisformában, amely hordozót és hatóanyagot tartalmaz és a hordozóhalzselatin, és a hatóanyag felszabadulása gyorsan végbemegyfolyadékkal való érintkezéskor. A találmány szerinti gyorsandiszpergálódó dózis formák különösen előnyösen orális adagolásúkészítmények, amelynél a hatóanyag- felszabadulás a szájüregben megyvégbe, a nyállal való érintkezés hatására. Ó
HU0201877A 1999-04-08 2000-04-07 Fast-dispersing dosage forms containing fish gelatin HU229892B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9908014.5A GB9908014D0 (en) 1999-04-08 1999-04-08 Pharmaceutical compositions
PCT/US2000/009278 WO2000061117A1 (en) 1999-04-08 2000-04-07 Fast-dispersing dosage forms containing fish gelatin

Publications (3)

Publication Number Publication Date
HUP0201877A2 true HUP0201877A2 (hu) 2002-11-28
HUP0201877A3 HUP0201877A3 (en) 2004-05-28
HU229892B1 HU229892B1 (en) 2014-11-28

Family

ID=10851154

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0201877A HU229892B1 (en) 1999-04-08 2000-04-07 Fast-dispersing dosage forms containing fish gelatin

Country Status (28)

Country Link
US (2) US6709669B1 (hu)
EP (1) EP1165053B1 (hu)
JP (1) JP4838939B2 (hu)
KR (1) KR100767076B1 (hu)
CN (1) CN1224381C (hu)
AT (1) ATE262890T1 (hu)
AU (1) AU761439B2 (hu)
BR (1) BR0009609A (hu)
CA (1) CA2369715C (hu)
CZ (1) CZ295324B6 (hu)
DE (1) DE60009472T2 (hu)
DK (1) DK1165053T3 (hu)
ES (1) ES2215645T3 (hu)
GB (1) GB9908014D0 (hu)
HK (1) HK1039066B (hu)
HU (1) HU229892B1 (hu)
IL (2) IL145783A0 (hu)
IS (1) IS2403B (hu)
MX (1) MXPA01010094A (hu)
NO (1) NO330196B1 (hu)
NZ (1) NZ515230A (hu)
PL (1) PL196572B1 (hu)
PT (1) PT1165053E (hu)
RO (1) RO122011B1 (hu)
RU (1) RU2242969C2 (hu)
TR (1) TR200102881T2 (hu)
WO (1) WO2000061117A1 (hu)
ZA (1) ZA200109089B (hu)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040023948A1 (en) * 1997-03-24 2004-02-05 Green Richard David Fast-dispersing dosage form containing 5-HT1 agonists
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
GB9910505D0 (en) * 1999-05-06 1999-07-07 Electrosols Ltd A method and apparatus for manufacturing consumable tablets
EP1238675A1 (en) * 2001-03-06 2002-09-11 Fuji Photo Film B.V. Recombinant gelatin-like proteins for use as plasma expanders
ITRM20010380A1 (it) * 2001-07-02 2003-01-02 Bioprogress Spa Composizione comprendente gelatina di pesce parzialmente idrolizzata e loro uso.
ATE303075T1 (de) * 2001-07-02 2005-09-15 Bioprogress Spa Teilhydrolysierte fischgelatine enthaltende zubereitungen und deren verwendung
KR100425226B1 (ko) * 2001-07-03 2004-03-30 주식회사 팜트리 아세클로페낙을 함유하는 경제적인 경구용 제제의 조성 및제법
GB0125061D0 (en) * 2001-10-18 2001-12-12 Norton Healthcare Ltd Pharmaceutical composition
DE60307082D1 (de) * 2002-05-07 2006-09-07 Ferring Bv In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
GB0226076D0 (en) * 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
UA93479C2 (en) * 2002-11-26 2011-02-25 Альк-Абелло A/C Allergen dosage form
WO2004047793A1 (en) * 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
US20040156894A1 (en) * 2003-02-07 2004-08-12 Grother Leon Paul Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
KR101136573B1 (ko) 2003-02-28 2012-04-23 알크-아벨로 에이/에스 당류 매트릭스를 갖는 제형
DE20321887U1 (de) 2003-11-10 2012-01-20 Allergan, Inc. Arzneimittel umfassend niedrige Dosierungen von Desmopressin
CA2545194C (en) 2003-11-10 2014-10-21 Seymour H. Fein Pharmaceutical compositions including low dosages of desmopressin
EP1530967B1 (en) 2003-11-13 2006-05-03 Ferring B.V. Blister pack and solid dosage form comprising desmopressin
US9241902B2 (en) 2003-12-17 2016-01-26 R.P. Scherer Technologies, Llc Chewable soft capsules containing ungelatinized starch
US7972621B2 (en) * 2004-06-03 2011-07-05 R.P. Scherer Technologies, Llc Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
WO2006058250A2 (en) * 2004-11-24 2006-06-01 Spi Pharma, Inc. Orally disintegrating compositions
CN101102748A (zh) * 2004-12-23 2008-01-09 麦克内尔-Ppc股份有限公司 具有感觉提示剂的在口中分裂的药物组合物
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
GB0510286D0 (en) * 2005-05-19 2005-06-29 Kilda Biolink As Composition
EP1898873A1 (en) 2005-05-19 2008-03-19 Kilda Biolink AS Gelatin-containing topical composition
TW200817049A (en) * 2006-06-05 2008-04-16 Verus Pharmaceuticals Inc Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms
US20070293581A1 (en) * 2006-06-05 2007-12-20 Malcolm Hill Methods for Buccal, Lingual or Sublingual Dosing Regimens of Epinephrine for the Treatment of Allergic Emergencies
EP2043613A1 (en) * 2006-07-14 2009-04-08 Fmc Corporation Solid form
TWI343262B (en) * 2006-09-26 2011-06-11 Schering Corp Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist
US20090214442A1 (en) * 2006-12-01 2009-08-27 Cephalon, Inc. Oral Transmucosal Nicotine Dosage Form
EP2101744A2 (en) * 2006-12-01 2009-09-23 Cima Labs Inc. Oral transmucosal nicotine dosage form
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
WO2008150526A1 (en) * 2007-06-04 2008-12-11 Shear/Kershman Laboratories, Inc. Tamper resistant lipid-based oral dosage form for opioid agonists
US20090004231A1 (en) 2007-06-30 2009-01-01 Popp Shane M Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
KR100905027B1 (ko) * 2007-10-03 2009-06-30 (주)씨엘팜 식용 필름
GB2453770A (en) 2007-10-19 2009-04-22 Reckitt Benckiser Healthcare Oral composition comprising a cooling agent
EP3093010A1 (en) * 2007-10-19 2016-11-16 Reckitt Benckiser Healthcare (UK) Limited Oral composition comprising a cooling agent
CA2716901C (en) * 2008-02-28 2018-07-03 R.P. Scherer Technologies, Llc Process to minimize polymorphism
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
NO2296686T3 (hu) 2008-05-21 2014-07-12
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US8420700B1 (en) * 2008-06-04 2013-04-16 James M. Bausch Tamper resistant lipid-based oral dosage form for sympathomimetic amines
ES2755029T3 (es) * 2008-08-05 2020-04-21 Wyeth Llc Liofilización por encima de la temperatura de colapso
JP2010143860A (ja) * 2008-12-19 2010-07-01 Chisso Corp タンパク質の安定化剤
TWI471127B (zh) 2009-04-29 2015-02-01 Intervet Int Bv 供人類使用之口服崩解錠劑的製備方法、所製得之口服崩解錠劑、以及含有該口服崩解錠劑的包裝物
RU2569756C2 (ru) 2009-06-18 2015-11-27 Эллерген, Инк. Безопасное применение десмопрессина
WO2011026080A1 (en) * 2009-08-31 2011-03-03 Wilmington Pharmaceuticals, Llc Fast disintegrating compositions of meloxicam, processes for preparation, and use to treat arthritis and/or pain
US9775819B2 (en) * 2009-09-16 2017-10-03 R.P. Scherer Technologies, Llc Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin
CN102933207B (zh) 2009-10-30 2018-02-02 Ix生物医药有限公司 快速溶解固体剂型
US10548839B2 (en) 2010-03-16 2020-02-04 Wei Tian Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
JO3112B1 (ar) 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
CN102834091B (zh) 2010-03-29 2015-04-22 辉凌公司 一种快速溶解药物组合物
EP2624815B8 (en) * 2010-10-08 2016-09-21 R.P. Scherer Technologies, LLC Oral vaccine fast-dissolving dosage form using starch
JP2012121850A (ja) * 2010-12-09 2012-06-28 Otsuka Pharmaceut Co Ltd アリピプラゾールの経口速溶性組成物
WO2012106058A2 (en) 2011-01-31 2012-08-09 New Market Pharmaceuticals Animal treatments
JP2011116764A (ja) * 2011-02-08 2011-06-16 Fine Seymour H 低用量デスモプレシンを含有する医薬組成物
NZ620897A (en) 2011-09-16 2016-07-29 Ferring Bv A fast dissolving pharmaceutical composition
AU2012379005B2 (en) 2012-05-02 2017-12-21 Newmarket Pharmaceuticals Llc Pharmaceutical compositions for direct systemic introduction
TW201422254A (zh) 2012-11-21 2014-06-16 Ferring Bv 用於速釋及延釋的組成物
JP2015172084A (ja) * 2015-07-06 2015-10-01 大塚製薬株式会社 アリピプラゾールの経口速溶性組成物
CN107397208B (zh) * 2016-07-20 2021-05-07 吴登成 以鱼鳔胶为主成分的功能食品及其用途
AU2017342160A1 (en) * 2016-10-13 2019-05-23 Catalent U.K. Swindon Zydis Limited Lyophilized pharmaceutical compositions for vaginal delivery
JP6968184B2 (ja) * 2016-10-25 2021-11-17 キャタレント・ユーケー・スウィンドン・ザイディス・リミテッド 速崩壊多層錠のための異なる密度の組成物
SG10202107367SA (en) 2016-12-31 2021-08-30 Bioxcel Therapeutics Inc Use of sublingual dexmedetomidine for the treatment of agitation
MY195591A (en) 2017-01-11 2023-02-02 Ferring Bv A Fast Disintegrating Pharmaceutical Composition
DE102017104472A1 (de) 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Schmelztablette enthaltend Burlulipase und daraus hergestellte pharmazeutische Zusammensetzung
US10517834B2 (en) * 2017-05-16 2019-12-31 Owen Murray Fast dissolving tablet formulations and methods of making thereof
EP3641774B1 (en) * 2017-06-20 2024-03-27 Seattle Gummy Company Pectin gummy composition and methods of making and using thereof
US10988638B2 (en) 2018-03-08 2021-04-27 Catalent U.K. Swindon Zydis Limited Process to reduce endotoxin in gelatin
CN112153969A (zh) * 2018-03-25 2020-12-29 拜尔哈文制药股份有限公司 用于cgrp相关障碍的瑞美吉泮
MX2020012377A (es) * 2018-05-27 2021-04-12 Biohaven Therapeutics Ltd Uso de tabletas de desintegracion orales de riluzol para el tratamiento de enfermedades.
SG11202012772XA (en) 2018-06-27 2021-01-28 Bioxcel Therapeutics Inc Film formulations containing dexmedetomidine and methods of producing them
EA202190544A1 (ru) 2018-08-16 2021-06-18 Биохэйвен Терапьютикс Лтд. Применение распадающихся в полости рта таблеток рилузола для лечения заболеваний
CA3127328A1 (en) * 2019-01-20 2020-07-23 Biohaven Pharmaceutical Holding Company Ltd. Cgrp antagonists for treating migraine breakthrough
SG11202109022UA (en) 2019-02-22 2021-09-29 Catalent Uk Swindon Zydis Ltd Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products
WO2020169988A1 (en) 2019-02-22 2020-08-27 Catalent U.K. Swindon Zydis Limited Minimizing aeration of suspensions during in-line mixing
GB2597577B (en) 2019-02-22 2023-09-20 Catalent Uk Swindon Zydis Ltd Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising ibuprofen
CN113438942A (zh) 2019-02-22 2021-09-24 康特伦英国斯温顿捷迪斯有限公司 在水性混悬液中保持通过无溶剂混合方法生产的功能性包衣api颗粒
KR20220049526A (ko) 2019-07-19 2022-04-21 바이오엑셀 테라퓨틱스 인코포레이티드 비-진정성 덱스메데토미딘 치료 양생법
WO2021132741A1 (ko) * 2019-12-23 2021-07-01 주식회사 피엘마이크로메드 색전 시술 입자 및 이의 제조방법
MX2023001004A (es) 2020-07-31 2023-03-01 Catalent Uk Swindon Zydis Ltd Composiciones farmaceuticas que comprenden un ingrediente farmaceutico activo (api) recubierto.
IL301250A (en) 2020-09-17 2023-05-01 Catalent Uk Swindon Zydis Ltd Surfactant use with high molecular weight fish gelatin-based dosage formulations to improve flow properties
US11672761B2 (en) * 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
US20240000809A1 (en) * 2020-11-16 2024-01-04 Orcosa Inc. Improved use of cannabinoids in the treatment of epilepsy
WO2022179635A1 (zh) * 2021-02-27 2022-09-01 北京兴源联合医药科技有限公司 一种β-烟酰胺单核苷酸冻干口服制剂
BR112023025552A2 (pt) 2021-06-11 2024-02-27 Orphai Therapeutics Inc Composições estabilizadas de apilimod e usos das mesmas
US20230064429A1 (en) * 2021-08-19 2023-03-02 Mind Medicine, Inc. IMMEDIATE RELEASE FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246013A1 (de) 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
DE2556561C2 (de) 1975-12-16 1983-04-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung von porösen Tabletten
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
US4139497A (en) * 1977-04-04 1979-02-13 The Dow Chemical Company Dehydrogenation catalyst tablet and method for making same
US4762719A (en) * 1986-08-07 1988-08-09 Mark Forester Powder filled cough product
US5035896A (en) * 1988-06-15 1991-07-30 Warner-Lambert Company Water insoluble drugs coated by coacervated fish gelatin
MC2034A1 (fr) * 1988-06-23 1990-05-30 Hoffmann La Roche Preparations
IL87344A (en) 1988-08-04 1992-03-29 Univ Bar Ilan Process for the production of gelatin from fish skins
US4935243A (en) 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US4946684A (en) 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
US5079018A (en) 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
EP0737473A1 (en) 1989-10-02 1996-10-16 Cima Labs, Inc. Effervescent dosage form
WO1992002133A1 (en) 1990-08-10 1992-02-20 Analytical Control Systems, Inc. Improved diagnostic and therapeutic compositions
FR2679451B1 (fr) 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
JP3290660B2 (ja) * 1991-10-11 2002-06-10 アボツト・ラボラトリーズ 特異的結合検定用の使用単位試薬組成物
DE69227467T2 (de) 1991-12-24 1999-04-22 Yamanouchi Pharma Co Ltd Intrabukkal desintegrierende zubereitung und ihre herstellung
JP2640570B2 (ja) 1992-01-13 1997-08-13 ファイザー インク． 強度が増加した錠剤の製造
US5298261A (en) 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
FR2702968B1 (fr) 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
ES2162867T3 (es) * 1993-07-09 2002-01-16 Scherer Corp R P Metodo de fabricacion de formas de dosificacion de farmacos liofilizados.
US5382437A (en) 1993-10-25 1995-01-17 Hunter Research Corporation Frozen liquified gas composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5595761A (en) * 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
US5484888A (en) 1994-03-08 1996-01-16 Holzer; David Gelatin production
US5603952A (en) 1994-12-30 1997-02-18 Tastemaker Method of encapsulating food or flavor particles using warm water fish gelatin, and capsules produced therefrom
GB9517062D0 (en) 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
US6083531A (en) 1996-04-16 2000-07-04 Novartis Consumer Health S.A. Fast disintegrating oral dosage form
US5879796A (en) * 1996-09-05 1999-03-09 E. I. Du Pont De Nemours And Company Organic/inorganic particulates
US6071963A (en) * 1996-11-06 2000-06-06 Roche Vitamins Inc. Water dispersible compositions
ID24487A (id) * 1997-04-03 2000-07-20 Bridge Pharma Inc Senyawa-senyawa benzosikloheptatiofen
FR2766089B1 (fr) 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
US6077540A (en) * 1997-08-08 2000-06-20 Bayer Corporation Gelatin spray coating
US6020003A (en) * 1998-02-23 2000-02-01 Basf Corporation Method of making spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US6284270B1 (en) * 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
US7972621B2 (en) 2004-06-03 2011-07-05 R.P. Scherer Technologies, Llc Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight

Also Published As

Publication number Publication date
KR100767076B1 (ko) 2007-10-17
CN1224381C (zh) 2005-10-26
CN1350450A (zh) 2002-05-22
HK1039066A1 (en) 2002-04-12
ATE262890T1 (de) 2004-04-15
NZ515230A (en) 2004-01-30
IS2403B (is) 2008-09-15
CZ20013588A3 (cs) 2002-06-12
HK1039066B (zh) 2004-08-13
GB9908014D0 (en) 1999-06-02
DK1165053T3 (da) 2004-06-01
CA2369715A1 (en) 2000-10-19
TR200102881T2 (tr) 2002-05-21
ZA200109089B (en) 2003-04-30
PL196572B1 (pl) 2008-01-31
JP2003524622A (ja) 2003-08-19
JP4838939B2 (ja) 2011-12-14
AU4333100A (en) 2000-11-14
IS6102A (is) 2001-10-04
PL354958A1 (en) 2004-03-22
WO2000061117A1 (en) 2000-10-19
ES2215645T3 (es) 2004-10-16
HU229892B1 (en) 2014-11-28
US9192580B2 (en) 2015-11-24
NO20014859L (no) 2001-11-19
RO122011B1 (ro) 2008-11-28
US20040076666A1 (en) 2004-04-22
PT1165053E (pt) 2004-06-30
IL145783A (en) 2006-10-31
AU761439B2 (en) 2003-06-05
DE60009472D1 (de) 2004-05-06
RU2242969C2 (ru) 2004-12-27
KR20020000160A (ko) 2002-01-04
BR0009609A (pt) 2002-02-13
US6709669B1 (en) 2004-03-23
NO20014859D0 (no) 2001-10-05
EP1165053A1 (en) 2002-01-02
DE60009472T2 (de) 2004-12-23
EP1165053B1 (en) 2004-03-31
EP1165053A4 (en) 2002-06-12
CA2369715C (en) 2006-03-21
HUP0201877A3 (en) 2004-05-28
NO330196B1 (no) 2011-03-07
CZ295324B6 (cs) 2005-07-13
IL145783A0 (en) 2002-07-25
MXPA01010094A (es) 2002-05-06

Similar Documents

Publication Publication Date Title
HUP0201877A2 (hu) Hal zselatint tartalmazó, gyorsan diszpergálódó dózis formák
HUP0203451A2 (hu) Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
HUP0105021A2 (hu) Javított hatóanyag-kibocsátású készítmények és eljárás az előállításukra
ATE211385T1 (de) Anwendungsformen zur behandlung der männlichen erektilen dysfunktion
HUP0101237A1 (hu) Elnyújtott kioldódású gyógyszerkészítmények
HUP0402154A2 (hu) Metformint és glibenklamidot tartalmazó gyógyászati készítmény II-es típusú diabetes mellitus kezelésére
HUP0500558A2 (hu) Alacsony dózisú entecavir formuláció és eljárás előállítására
UA84266C2 (uk) Дозована лікарська форма у вигляді таблетки або пелети для перорального введення, яка містить інгібітор pde 4 та полівінілпіролідон, способи її одержання та застосування
HUP0303182A2 (hu) Gyógyászati készítmények
HUP0301349A2 (hu) IL-11-tartalmú készítmények
HUP0204109A2 (en) Oral preparations for diabetes
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
HUP0301390A2 (hu) Valzartánt tartalmazó orális gyógyászati készítmény
IS7006A (is) Tvívetnis 3-piperidínóprópíófenon og lyf sem innihalda téð efnasambönd
SE9700885D0 (sv) New pharmaceutical formulation
HUP0104647A2 (hu) Hatóanyagként tilidin-mezilátot tartalmazó, szabályozott hatóanyag-leadású gyógyszerkészítmény
HUP0105481A2 (hu) Klaritromicint vagy származékait tartalmazó gyógyászati készítmények és eljárás előállításukra, valamint alkalmazásuk
HUP0002346A1 (hu) Emlősök elmezavarainak kezelésére szolgáló gyógyszerkészítmény
HUP0203148A2 (hu) Mirtazapint tartalmazó orálisan dezintegrálódó készítmény
HUP0202324A2 (hu) Prukaloprid orális oldat
HUP0203717A2 (hu) Izotretinoint tartalmazó új biológiailag hasznos gyógyszerkészítmény és eljárás az előállítására
EP1273301A3 (en) Pharmaceutical preparations based on active ingredients susceptible to illict administration
MY141008A (en) Oral formulations of deoxypeganine and their uses
HUP0100542A2 (hu) Progesztogént és anti-progesztogént tartalmazó kit, eljárás előállítására és a vegyületek alkalmazása fogamzásgátló szer előállítására
HUP0301415A2 (hu) Eljárás megnövelt stabilitású egészségvédż termékek formulázására

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: CARDINAL HEALTH 409, INC., US

Free format text: FORMER OWNER(S): R.P. SCHERER CORPORATION, US

NF4A Restoration of patent protection